+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Caspofungin"

Antifungal Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antifungal Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Loading Indicator

Caspofungin is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida species. It is a member of the echinocandin class of antifungal drugs, which are used to treat serious fungal infections in immunocompromised patients. Caspofungin is typically used in combination with other antifungal drugs, such as amphotericin B or fluconazole, to treat infections that are resistant to other antifungal agents. It is also used to treat infections caused by Aspergillus species, which are often difficult to treat. Caspofungin is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is also well tolerated, with few side effects. As such, it is an important part of the infectious diseases drugs market. Companies in the caspofungin market include Merck & Co., Pfizer, Astellas Pharma, and Bristol-Myers Squibb. Show Less Read more